KOPRAN
Back to Cashflow Statement
|
KOPRAN Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-19 Cr | ₹11 Cr | ₹0.69 Cr | ₹1.53 Cr | ₹4.93 Cr |
What is the latest Net Cash Inflow / Outflow ratio of KOPRAN ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-19 Cr |
| Mar2025 | ₹11 Cr |
| Mar2024 | ₹0.69 Cr |
| Mar2023 | ₹1.53 Cr |
| Mar2022 | ₹4.93 Cr |
How is Net Cash Inflow / Outflow of KOPRAN Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-19 Cr | Negative | |
| Mar2025 | ₹11 Cr | 1,537.70 | |
| Mar2024 | ₹0.69 Cr | -54.52 | |
| Mar2023 | ₹1.53 Cr | -69.02 | |
| Mar2022 | ₹4.93 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹918.4 Cr | 5.7% | -6.8% | 13.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | 5.7% |
-6.8% |
13.9% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses